Are new drugs really that bad for patients?

Sure, drug development and marketing are part of a standard business model in our country, particularly with massive funding toward leveraging marketing to drive product profitability. But according to a piece published on FiercePharma last year, most Pharma companies likely don’t spend more money on marketing than research and development. When you consider business operations, as part…